News

BioStat® Research
& Development Centre

2024 2023 2022 older
Post-stroke aphasia. Biostat in a clinical trial in the US
15
February
2024
Post-stroke aphasia. Biostat in a clinical trial in the US
Biostat's Research and Development Center has prepared a randomization system for a clinical trial being conducte...
It's been a good year! Summary of 2023 at Biostat
12
February
2024
It's been a good year! Summary of 2023 at Biostat
It's been a good year! Summary of 2023 at Biostat We summarize 2023 at Biostat Group. We are p...
08
June
2018
Cooperation with Celon Pharma
08
June
2018

Cooperation with Celon Pharma

Cooperation with Celon Pharma

Cooperation with Celon Pharma

We believe that our development and position are inseparably linked to innovations.

Leading Polish companies like Celon Pharma, by providing modern therapies to their patients build the quality of pharmaceutical industry. We discern our own role in having active influence on developing new therapies. Our company supports scientific-developmental activity of Celon Pharma by providing them with eCRF.bizTM software within the project "Nowa terapia S-ketaminą w leczeniu depresji lekoopornej" [“New use of S-Ketamine in treating drug-fast depression”] .

"We aid initiatives which create friendly environment for science, medicine and innovativeness, as well as we assist in having everyone fully use their potential. We feel responsible for developing innovativeness both in Poland and in the world, as we are pleased that we may participate in such projects” – Chairman, Rafał Piszczek

Thank you for the confidence You place in us every day.

Copyright© 2023 Biostat
Cookies